PRKAA2 and hypertensive disorder: Mitochondrial dysfunction and the inhibition of energy metabolism‐related proteins, AMP‐activated protein kinase (AMPK) and Sirtuin 1/3 (SIRT1/3), play an important role in the progression of hypertension.